SKI Market

Indian Indices

Nifty

22,302.50 0.00
(0.00%)

Sensex

73,067.34 -399.05
( -0.54%)

Bank Nifty

48,021.10 -264.25
( -0.55%)

Nifty IT

33,335.15 -137.85
( -0.41%)

Global Indices

Nasdaq

16,302.76 -29.80
(-0.18%)

Dow Jones

39,056.39 172.13
(0.44%)

Hang Seng

18,313.86 -165.51
(-0.90%)

Nikkei 225

38,202.37 -632.73
(-1.63%)

Forex

USD-INR

83.48 0.01
(0.01%)

EUR-INR

89.85 -0.05
(-0.05%)

GBP-INR

104.64 -0.22
(-0.21%)

JPY-INR

0.54 0.00
(-0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Par Drugs & Chemicals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

535341

INE04LG01015

63.8765226

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PAR

22.29

317.03

EPS(TTM)

Face Value()

Div & Yield %

11.56

Back

par drugs & chemicals ltd

Par Drugs & Chemicals standalone net profit rises 31.10% in the September 2023 quarter

Oct 30,2023

Net profit of Par Drugs & Chemicals rose 31.10% to Rs 4.89 crore in the quarter ended September 2023 as against Rs 3.73 crore during the previous quarter ended September 2022. Sales rose 4.31% to Rs 25.89 crore in the quarter ended September 2023 as against Rs 24.82 crore during the previous quarter ended September 2022.

Particulars	Quarter Ended
	Sep. 2023	Sep. 2022	% Var.
Sales	25.89	24.82	4
OPM %	28.47	23.77	-
PBDT	7.39	5.89	25
PBT	6.54	4.98	31
NP	4.89	3.73	31

22,302.50 0.00 (0.00%)

73,067.34 -399.05 ( -0.54%)

48,021.10 -264.25 ( -0.55%)

33,335.15 -137.85 ( -0.41%)

16,302.76 -29.80 (-0.18%)

39,056.39 172.13 (0.44%)

18,313.86 -165.51 (-0.90%)

38,202.37 -632.73 (-1.63%)

83.48 0.01 (0.01%)

89.85 -0.05 (-0.05%)

104.64 -0.22 (-0.21%)

0.54 0.00 (-0.43%)